INMACULADA RAMOS GARCIA – ENSAYO CLINICO COMERCIAL – GENMAB A/S
A Phase 2, Multicenter, Randomized, Open-Label Trial of GEN1046 as Monotherapy and in Combination With Anti-cancer Therapy in Subjects With Relapsed/Refractory Metastatic Non-Small Cell Lung Cancer After Treatment With Standard of Care Therapy With an Immune Checkpoint Inhibitor
by prodriguez | Jul 3, 2024 | Clinical Trials, Ensayos Clínicos - CIMO-01 | 0 comments